40 uger efter afslutning af behandlingsperioden var procentdelen af de patienter, som stadig var ikkerygere, 23% hos de der havde taget CHAMPIX, og 9% blandt de der havde taget placebo.
40 weeks after the end of the treatment period, the percentage of patients who were still non-smokers was 23% among those who had taken CHAMPIX, and 9% among those who had taken a placebo.